InsiderClue
Insiders · Profile

MANCHESTER KEITH S

Director at Roivant Sciences · Director at Arbutus Biopharma. Filing since 10 Nov 2022. CIK 0001244828

ROIV Roivant Sciences Ltd. Director · 14 trades ABUS Arbutus Biopharma Corp Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ROIV Roivant Sciences Ltd.
30 Jun 2026
Director
Sold at will
200,000
$7.09M
10.3%
ROIV Roivant Sciences Ltd.
30 Jun 2026
Director
Sold at will
12,380
$436.77K
0.1%
ROIV Roivant Sciences Ltd.
29 Jun 2026
Director
Sold at will
800,000
$27.64M
5.5%
ROIV Roivant Sciences Ltd.
26 Jun 2026
Director
Sold at will
625,783
$21.28M
4.1%
ROIV Roivant Sciences Ltd.
13 Feb 2026
Director
Sold at will
375,784
$9.96M
2.4%
ROIV Roivant Sciences Ltd.
12 Feb 2026
Director
Sold at will
425,000
$11.37M
2.7%
ROIV Roivant Sciences Ltd.
11 Feb 2026
Director
Sold at will
425,000
$11.33M
2.6%
ROIV Roivant Sciences Ltd.
17 Dec 2025
Director
Sold at will
777,332
$17.94M
4.5%
ROIV Roivant Sciences Ltd.
16 Dec 2025
Director
Sold at will
917,282
$21.13M
5.1%
ROIV Roivant Sciences Ltd.
19 Nov 2025
Director
Sold at will
1,300,000
$26.30M
6.7%
ROIV Roivant Sciences Ltd.
25 Sep 2024
Director
Sold at will
134,948
$1.59M
9.6%
ROIV Roivant Sciences Ltd.
24 Sep 2024
Director
Sold at will
368,052
$4.28M
20.7%
ABUS Arbutus Biopharma Corp
14 Aug 2024
Director
Sold at will
8,846
$32.64K
16.1%
ROIV Roivant Sciences Ltd.
28 Sep 2023
Director
Sold at will
6,896,144
$79.65M
57.9%
ROIV Roivant Sciences Ltd.
10 Nov 2022
Director
Sold, plan not stated
3,922,504
$18.63M
41.8%
15 decisions on file.